The efficacy and tolerability of modafinil for fatigue and daytime sleepiness in cancer patients: preliminary study
Not Applicable
Recruiting
- Conditions
- Not Applicable
- Registration Number
- KCT0001412
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
?solid cancer patient
?age of 20-65 years old
?Subjects who scored =4 or >4 on the Brief Fatigue Inventory
?Subjecst with informed consent
Exclusion Criteria
?metastatic cancer(stage IV)
?with psychotic symptoms such as delusion and hallucination or with suicidal risk
?with delirium or dementia
?current medication of cognitive enhancer or psychostimulant
?uncontrolled medical illness
?current medications that are contraindicated or not recommended for co-administration with modafinil
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method severity of fatigue (score for Brief Fatigue Inventory)
- Secondary Outcome Measures
Name Time Method quantitative electrocephalography;cognitive function test;sleepwake cycle;depression/anxiety